
This episode of Let’s Talk Medtech is a double-header. We speak with Glenn Hunzinger, US Pharma & Life Science Leader for PricewaterhouseCoopers about the state of medtech M&A and take a dive into the Pharmaceutical and life sciences deals insights: 2021 midyear outlook report.
Then, Omar Ford, MD+DI’s Managing Editor, delves into the controversial Illumina/Grail merger.